Article info
Original article
Betamethasone dipropionate compounding for cutaneous T-cell lymphoma management
- Correspondence to Helena Ribeiro, Department of Nanomedicine and Drug Delivery Systems, iMed.UL (Research Institute for Medicines and Pharmaceutical Sciences) Faculdadec de Farmácia da Universidade de Lisboa, Av. Prof. Gama Pinto, Lisboa 1649-003, Portugal; hribeiro{at}campus.ul.pt
Citation
Betamethasone dipropionate compounding for cutaneous T-cell lymphoma management
Publication history
- Received July 13, 2016
- Revised November 8, 2016
- Accepted November 15, 2016
- First published December 1, 2016.
Online issue publication
December 19, 2017
Article Versions
- Previous version (1 December 2016).
- Previous version (27 March 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/